可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:
[1] 王月刚,吴平生. 干细胞移植治疗冠心病应用进展[J]. 心脏杂志, 2007, 19(1):91-95.
[2] 林强,陈书艳. 骨髓间充质干细胞治疗心肌梗死的机制[J]. 心脏杂志, 2008, 20(4):498-500.
[3] 朱洪生,连锋,王彦婷,等.永生型骨髓问充质干细胞体外诱导为心肌样细胞的实验研究[J]. 中华心血管病杂志,2004, 32(1):59-63.
[4] 王莹,龚卫琴,张珊红. 骨髓间充质干细胞不同移植方法对心肌梗死大鼠心脏的保护作用[J]. 心脏杂志, 2007, 19(3):266-268.
[5] 金鹏,金丽娟,朱红,等. 自体骨髓间充质干细胞移植对急性心肌梗死后心功能的影响[J]. 心脏杂志, 2008, 20(1):9-12.
[6] Kuethe F, Figulla HR, Voth M, et al. Mobilization of stem cells by granulocyte colony-stimulating factor for the regeneration of myocardial tissue after myocardial infarction[J]. Dtsch Med Wochenschr, 2004, 129(9):424-428.
[7] Li J, Goodyer CG, Fellows F, et al. Stem cell factor/c-Kit interactions regulate human islet-epithelial cluster proliferation and differentiation[J]. Int J Biochem Cell Biol, 2006, 38(5-6):961-972.
[8] Bashamboo A, Taylor AH, Samuel K, et al. The survival of differentiating embryonic stem cells is dependent on the SCF-KIT pathway[J]. J Cell Sci, 2006, 119(Pt 15):3039-3046.
[9] 杨敏,闫纯英,吴贤仁,等. 干细胞因子动员骨髓干细胞归巢梗死心肌的特性变化[J]. 中华临床康复, 2005, 9(26):67-70.
[10]Harada M, Qin Y, Takano H, et al. G-CSF prevents cardiac remodeling after myocardial infarction by activating the Jak-Stat pathway in cardiomyocytes[J]. Nat Med, 2005, 11(3): 305-311.
[11]Sugano Y, Anzai T, Yoshikawa T, et al. Granulocyte colony-stimulating factor attenuates early ventricular expansion after experimental myocardial infarction[J]. Cardiovasc Res, 2005, 65(2):446-456.
[12]Murry CE, Soonpaa MH, Reinecke H, et al. Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts[J]. Nature, 2004, 428(6983):664-668.
[13]刘红军,段海峰,鲁茁壮,等. 肝细胞生长因子对骨髓间充质干细胞生物学特性的影响[J]. 中国实验血液学杂志, 2005, 13(6):1044-1048.
[14]Forte G, Minieri M. Hepatocyte growth factor effects on mesenchymal stem cells: proliferation, migration, and differentiation[J]. Stem cells, 2006, (1):23-33.
[15]方天翎,闵军,邓小耿,等. 肝细胞生长因子诱导骨髓间充质干细胞分化为心肌细胞[J]. 中国病理生理杂志, 2004, 20(7):1167-1170.
[16]Linke A, Muller P, Nurzynska D, et al. Stem cells in the dog heart are self-renewing, clonogenic, and multipotent and regenerate infarcted myocardium, imp roving cardiac function[J]. Proc Natl Acad Sci U S A, 2005, 102(25):8966-8971.
[17]Urbanek K, Rota M, Cascapera S, et al. Cardiac stem cells possess growth factor-receptor systems that after activation regenerate the infarcted myocardium, improving ventricular function and long-term survival[J]. Circ Res, 2005, 97(7):663-673.
[18]Fraser JK, Wulur I, Alfonso Z, et al. Fat tissue: an under appreciated source of stem cells for biotechnology[J]. Trends Biotechnol, 2006, 24(4):150-154.
[19]Gerritsen ME. HGF and VEGF: A Dynamic Duo[J]. Circ Res, 2005, 96:272-273.
[20]Suzuki YJ, Kitta K, Day RM, et al. Hepatocyte growth factor induces GATA-4 phosphorylation and cell survival in cardiac muscle cells[J]. J Biol Chem, 2003, 278(7):4705-4712.
[21]Yumoto A, Fukushima Kusano K, Nakamura K, et al. Hepatocyte growth factor gene therapy reduces ventricular arrhythmia in animal models of myocardial ischemia[J]. Acta Med Okayama, 2005, 59(3):73-78.
[22]Nakamura T, Matsumoto K, Mizuno S, et al. Hepatocyte growth factor prevents tissue fibrosis, remodeling, and dysfunction incardiomyopathic hamster hearts[J]. Am J Physiol Heart Circ Physiol, 2005, 288(5):H2131-H2139.
[23]Futamatsu H, Suzuki J, Mizuno S, et al. Hepatocyte growth factor ameliorates the progression of experimental autoimmune myocarditis: a potential role for induction of T helper 2 cytokines[J]. Circ Res, 2005, 96(8): 823-830.